Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor
Previous Article
UAAP... TSU revo niw lufegnev ot ellaS
Next Article
Which... ziuq ytilanosrep ruo ekaT ?uoy